Rabelink, T J <br/><br/>
Endothelin blockers and renal protection: a new strategy to prevent end-organ damage in cardiovascular disease?  [electronic resource] 

 -  Cardiovascular research  Sep 1998 
 - 543-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0008-6363 
<br/><br/><label>Standard No.: </label>10.1016/s0008-6363(98)00155-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Animals<br/>Aspartic Acid Endopeptidases--antagonists & inhibitors<br/>Cardiovascular Diseases--complications<br/>Diabetic Nephropathies--metabolism<br/>Endothelin Receptor Antagonists<br/>Endothelin-1--metabolism<br/>Endothelin-Converting Enzymes<br/>Enzyme Inhibitors--therapeutic use<br/>Hemodynamics--drug effects<br/>Humans<br/>Kidney Failure, Chronic--etiology<br/>Metalloendopeptidases<br/>Renin-Angiotensin System--drug effects